BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

207 related articles for article (PubMed ID: 36239933)

  • 1. Young-Onset Breast Cancer Outcomes by Time Since Recent Childbirth in Utah.
    Zhang Z; Bassale S; Jindal S; Fraser A; Guinto E; Anderson W; Mori M; Smith KR; Schedin P
    JAMA Netw Open; 2022 Oct; 5(10):e2236763. PubMed ID: 36239933
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Association Between Postpartum Breast Cancer Diagnosis and Metastasis and the Clinical Features Underlying Risk.
    Goddard ET; Bassale S; Schedin T; Jindal S; Johnston J; Cabral E; Latour E; Lyons TR; Mori M; Schedin PJ; Borges VF
    JAMA Netw Open; 2019 Jan; 2(1):e186997. PubMed ID: 30646210
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Postpartum Breast Cancer and Survival in Women With Germline BRCA Pathogenic Variants.
    Zhang Z; Ye S; Bernhardt SM; Nelson HD; Velie EM; Borges VF; Woodward ER; Evans DGR; Schedin PJ
    JAMA Netw Open; 2024 Apr; 7(4):e247421. PubMed ID: 38639936
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Analysis of Breast Cancer Family History, Estrogen Receptor Status, and Breast Cancer Outcomes in Sweden.
    Zhang Y; Wang QL; Zeng E; He W; Czene K
    JAMA Netw Open; 2023 Jun; 6(6):e2318053. PubMed ID: 37310740
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Breast Cancer Risk After Recent Childbirth: A Pooled Analysis of 15 Prospective Studies.
    Nichols HB; Schoemaker MJ; Cai J; Xu J; Wright LB; Brook MN; Jones ME; Adami HO; Baglietto L; Bertrand KA; Blot WJ; Boutron-Ruault MC; Dorronsoro M; Dossus L; Eliassen AH; Giles GG; Gram IT; Hankinson SE; Hoffman-Bolton J; Kaaks R; Key TJ; Kitahara CM; Larsson SC; Linet M; Merritt MA; Milne RL; Pala V; Palmer JR; Peeters PH; Riboli E; Sund M; Tamimi RM; Tjønneland A; Trichopoulou A; Ursin G; Vatten L; Visvanathan K; Weiderpass E; Wolk A; Zheng W; Weinberg CR; Swerdlow AJ; Sandler DP
    Ann Intern Med; 2019 Jan; 170(1):22-30. PubMed ID: 30534999
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Clinical characteristics and prognosis of postpartum breast cancer.
    Paik PS; Choi JE; Lee SW; Lee YJ; Kang YJ; Lee HJ; Bae SY;
    Breast Cancer Res Treat; 2023 Nov; 202(2):275-286. PubMed ID: 37542632
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Overall survival is the lowest among young women with postpartum breast cancer.
    Shagisultanova E; Gao D; Callihan E; Parris HJ; Risendal B; Hines LM; Slattery ML; Baumgartner K; Schedin P; John EM; Borges VF
    Eur J Cancer; 2022 Jun; 168():119-127. PubMed ID: 35525161
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The prognostic effect of estrogen receptor status differs for younger versus older breast cancer patients.
    Sopik V; Sun P; Narod SA
    Breast Cancer Res Treat; 2017 Sep; 165(2):391-402. PubMed ID: 28601929
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Postpartum breast cancer has a distinct molecular profile that predicts poor outcomes.
    Jindal S; Pennock ND; Sun D; Horton W; Ozaki MK; Narasimhan J; Bartlett AQ; Weinmann S; Goss PE; Borges VF; Xia Z; Schedin P
    Nat Commun; 2021 Nov; 12(1):6341. PubMed ID: 34732713
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Data describing the poor outcome associated with a breast cancer diagnosis in the post-weaning period.
    Lefrère H; Floris G; Schmidt MK; Neven P; Warner E; Cardonick E; Peccatori FA; Loibl S; Maggen C; De Mulder H; Jerzak KJ; Lambrechts D; Lenaerts L; Amant F
    Data Brief; 2021 Oct; 38():107354. PubMed ID: 34557571
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Long-term Mortality in Individuals Diagnosed With Cancer During Pregnancy or Postpartum.
    Cairncross ZF; Shack L; Nelson G; Friedenreich CM; Ray J; Fell DB; Lisonkova S; Bhatti P; Sikdar K; McMorris C; Metcalfe A
    JAMA Oncol; 2023 Jun; 9(6):791-799. PubMed ID: 37022714
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Postpartum diagnosis demonstrates a high risk for metastasis and merits an expanded definition of pregnancy-associated breast cancer.
    Callihan EB; Gao D; Jindal S; Lyons TR; Manthey E; Edgerton S; Urquhart A; Schedin P; Borges VF
    Breast Cancer Res Treat; 2013 Apr; 138(2):549-59. PubMed ID: 23430224
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Breast cancer diagnosed in the post-weaning period is indicative for a poor outcome.
    Lefrère H; Floris G; Schmidt MK; Neven P; Warner E; Cardonick E; Peccatori FA; Loibl S; Maggen C; De Mulder H; Jerzak KJ; Lambrechts D; Lenaerts L; Amant F
    Eur J Cancer; 2021 Sep; 155():13-24. PubMed ID: 34330022
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Predictors of time to death after distant recurrence in breast cancer patients.
    Sopik V; Sun P; Narod SA
    Breast Cancer Res Treat; 2019 Jan; 173(2):465-474. PubMed ID: 30328050
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Association of the Implant Surface Texture Used in Reconstruction With Breast Cancer Recurrence.
    Lee KT; Kim S; Jeon BJ; Pyon JK; Mun GH; Ryu JM; Lee SK; Yu J; Kim SW; Lee JE; Nam SJ; Bang SI
    JAMA Surg; 2020 Dec; 155(12):1132-1140. PubMed ID: 33026424
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Differences in breast cancer stage at diagnosis and cancer-specific survival by race and ethnicity in the United States.
    Iqbal J; Ginsburg O; Rochon PA; Sun P; Narod SA
    JAMA; 2015 Jan; 313(2):165-73. PubMed ID: 25585328
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Reproductive factors and risk of hormone receptor positive and negative breast cancer: a cohort study.
    Ritte R; Tikk K; Lukanova A; Tjønneland A; Olsen A; Overvad K; Dossus L; Fournier A; Clavel-Chapelon F; Grote V; Boeing H; Aleksandrova K; Trichopoulou A; Lagiou P; Trichopoulos D; Palli D; Berrino F; Mattiello A; Tumino R; Sacerdote C; Quirós JR; Buckland G; Molina-Montes E; Chirlaque MD; Ardanaz E; Amiano P; Bueno-de-Mesquita HB; van Gils CH; Peeters PH; Wareham N; Khaw KT; Key TJ; Travis RC; Weiderpass E; Dumeaux V; Lund E; Sund M; Andersson A; Romieu I; Rinaldi S; Vineis P; Merritt MA; Riboli E; Kaaks R
    BMC Cancer; 2013 Dec; 13():584. PubMed ID: 24321460
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Mortality after breast cancer as a function of time since diagnosis by estrogen receptor status and age at diagnosis.
    Jayasekara H; MacInnis RJ; Chamberlain JA; Dite GS; Leoce NM; Dowty JG; Bickerstaffe A; Win AK; Milne RL; Giles GG; Terry MB; Eccles DM; Southey MC; Hopper JL
    Int J Cancer; 2019 Dec; 145(12):3207-3217. PubMed ID: 30771221
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Association of Adjuvant Hormone Therapy Timing With Overall Survival Among Patients With Hormone Receptor-Positive Human Epidermal Growth Factor Receptor-2-Negative Early Breast Cancer Without Chemotherapy.
    Fu F; Yu L; Zeng B; Chen M; Guo W; Chen L; Lin Y; Hou J; Li J; Li Y; Li S; Chen X; Zhang W; Jin X; Cai W; Zhang K; Chen H; Qiu Y; Nie Q; Wang C; Jacobs L
    JAMA Netw Open; 2022 Feb; 5(2):e2145934. PubMed ID: 35166783
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Molecular and Clinical Characterization of Postpartum-Associated Breast Cancer in the Carolina Breast Cancer Study Phase I-III, 1993-2013.
    Vohra SN; Walens A; Hamilton AM; Sherman ME; Schedin P; Nichols HB; Reeder-Hayes KE; Olshan AF; Love MI; Troester MA
    Cancer Epidemiol Biomarkers Prev; 2022 Mar; 31(3):561-568. PubMed ID: 34810211
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.